These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

56 related articles for article (PubMed ID: 369027)

  • 1. [Methods of determining principal hypolipidemic agents].
    Moachon G; Houin G; Tillement JP
    Therapie; 1978; 33(5):587-98. PubMed ID: 369027
    [No Abstract]   [Full Text] [Related]  

  • 2. [Picafibrate. I. Physico-chemical and analytical characteristics].
    Dubois MJ; Dubois J; Vezin JC; Cousse H
    Boll Chim Farm; 1977 Sep; 116(9):520-9. PubMed ID: 145868
    [No Abstract]   [Full Text] [Related]  

  • 3. [Antilipemic agents available after the ban on clofibrate: clinical-pharmacological view].
    Mertz DP
    Fortschr Med; 1979 Apr; 97(15):695-6, 698. PubMed ID: 456970
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A high pressure liquid chromatographic determination of p-chlorophenoxyisobutyric acid and its comparison to a GLC and an ultra violet spectrophotometric method.
    Robinson WT; Cosyns L; Kraml M
    Clin Biochem; 1978 Oct; 11(5):214-7. PubMed ID: 729163
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Binding to plasma lipoproteins of chlorophenoxyisobutyric, tibric and nicotinic acids and their esters.
    Beaumont JL; Dachet C
    Proc R Soc Med; 1976; 69 Suppl 2(Suppl 2):41-3. PubMed ID: 1019153
    [No Abstract]   [Full Text] [Related]  

  • 6. [Serum gas chromatographic determination of hypolipemic agents derived from clofibric acid].
    Cailleux A; Allain P
    Therapie; 1976; 31(5):631-6. PubMed ID: 1013955
    [No Abstract]   [Full Text] [Related]  

  • 7. Characterization of glucuronic acid conjugates of a novel angiotensin receptor antagonist.
    Bowers GD; Eddershaw PJ; Hughes SY; Manchee GR; Oxford J
    Rapid Commun Mass Spectrom; 1994 Feb; 8(2):217-21. PubMed ID: 8155901
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Animal models for screening hypolipidemic drugs. III. The response of nicotinic acid and clofibrate in fed and fasted old rats.
    Magnusson O; Andersson I; Nordlund L
    Z Versuchstierkd; 1978; 20(1):46-58. PubMed ID: 636683
    [No Abstract]   [Full Text] [Related]  

  • 9. Drug interactions and side effects of hypolipidemic drugs.
    Schwandt P
    Int J Clin Pharmacol Biopharm; 1979 Aug; 17(8):351-6. PubMed ID: 489202
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pantetheine and pantethine esters with hypolipidemic nicotinic acid derivatives.
    Picciòla G; Calvi E; Ravenna F; Gentili P; Manzardo S; Riva M
    Arzneimittelforschung; 1985; 35(12):1768-71. PubMed ID: 4096728
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Determination of nicotinic acid in injections by high-performance liquid chromatography].
    Tokunaga H; Okada S; Kimura T
    Eisei Shikenjo Hokoku; 1989; (107):108-12. PubMed ID: 2636910
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Selection of methods for therapeutic drug monitoring.
    Stewart MJ
    Contemp Issues Clin Biochem; 1985; 3():61-77. PubMed ID: 3842110
    [No Abstract]   [Full Text] [Related]  

  • 13. Colorimetric and gas chromatographic analyses of arecoline in capsule preparations.
    Kovensky BJ; Poole CW
    J Pharm Sci; 1970 Nov; 59(11):1651-2. PubMed ID: 5495496
    [No Abstract]   [Full Text] [Related]  

  • 14. [Effect of ethofibrate [2-(nicotinoyloxy)ethyl-p-chlorophenoxyisobutyrate] on lipid metabolism. I. Effect on blood lipids in normal and hyperlipemic rats].
    Maroto ML; Priego JG; Piña M; Catalán RE
    Arch Farmacol Toxicol; 1978 Apr; 4(1):25-7. PubMed ID: 697396
    [No Abstract]   [Full Text] [Related]  

  • 15. [Effect of ethofibrate [2-(nicotinoyloxy)ethyl-p-chlorophenoxyisobutyrate] lipid metabolism. II. Effects on the incorporation of various isotopic precursors in rat liver].
    Priego JG; Maroto ML; Piña M; Catalán RE
    Arch Farmacol Toxicol; 1978 Apr; 4(1):28-30. PubMed ID: 697397
    [No Abstract]   [Full Text] [Related]  

  • 16. [Treatment of coronary heart disease with diet and lipid-reducing agents].
    Sailer D; Kolb S
    Fortschr Med; 1982 Nov; 100(43):2005-10. PubMed ID: 7152437
    [No Abstract]   [Full Text] [Related]  

  • 17. [Lipid depression by etofibrate in a comparative study in rats with artificial hyperlipidemia].
    Sterner W; Schultz A
    Arzneimittelforschung; 1974 Dec; 24(12):1990-2. PubMed ID: 4480360
    [No Abstract]   [Full Text] [Related]  

  • 18. Electrophilic reactions of acyl-linked glucuronides. Formation of clofibrate mercapturate in humans.
    Stogniew M; Fenselau C
    Drug Metab Dispos; 1982; 10(6):609-13. PubMed ID: 6130909
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Aminophenyl ether compound (YM-95831), a new hypolipidemic agent with a high density lipoprotein elevating activity in rats.
    Ohata I; Sakamoto N; Nitatori R; Maeno H
    Arzneimittelforschung; 1983; 33(2):237-41. PubMed ID: 6682662
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Advances in the analysis of phenolic compounds in products derived from bees.
    Gómez-Caravaca AM; Gómez-Romero M; Arráez-Román D; Segura-Carretero A; Fernández-Gutiérrez A
    J Pharm Biomed Anal; 2006 Jun; 41(4):1220-34. PubMed ID: 16621403
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.